...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

4th International Definiens Symposium to Feature More Than 20 Expert Presenters

| Print |
Tuesday, 05 March 2013 15:00 (UTC + 1)

definiens logo

Speakers will discuss trends and opportunities in image and data analysis for digital pathology at Harvard Medical School in Boston

Munich, Germany, March 5, 2013 / B3C newswire / –Definiens, the global leader of image and data analysis solutions for quantitative digital pathology, today announced it will host more than 20 distinguished speakers at the 4th International Definiens Symposium, featuring discussions on image and data analysis in digital pathology. The symposium will be held at the Joseph B. Martin Conference Center on Harvard Medical School campus in Boston, MA on May 13-15, 2013.

This annual event will bring together global leading experts from pharmaceutical, biotech and diagnostics companies, as well as academic medical centers to share groundbreaking research and insights on digital pathology. Presenters will highlight how Definiens technology is used in practice to accelerate R&D and discovery of new drugs and biomarkers in automated workflows and how it can be used to innovate new diagnostic tests, increase the success rate of development, reduce time to market and manage the diversity of a broad range of image analysis tasks.

“Definiens is committed to helping researchers and clinicians generate new knowledge that supports personalized medicine and better decisions in research, diagnostics and therapy,” said Thomas Heydler, CEO of Definiens. “Advanced image and data analysis is critical to enhancing diagnostics and clinical digital pathology. We’re thrilled to be working with such an esteemed group of presenters to share knowledge that can lead to improved decision making and better outcomes for patients.”

The symposium will feature plenary talks as well as hands-on workshops to encourage collaboration and the sharing of best practices. Sessions will include:

  • Taking Tissue Diagnostics into the 21st Century
  • Advancing Drug Development
  • Embracing Digital Pathology - The Business Perspective (includes panel discussion)

“The Definiens symposium has become a leading forum for discussions on image and data analysis in digital pathology,” said Dr. Thomas Nifong, VP of Clinical Operations, Metamark Genetics. “It provides an important setting for sharing new academic and clinical research and promoting advancements in the industry.”

What: 4th International Definiens Symposium: Empowering Digital Pathology

When: May 13-15, 2013

Who Should Attend: Researchers and clinicians in the life sciences, diagnostic biomarkers and healthcare industries

Where: Joseph B. Martin conference center, Harvard Medical School Campus, Boston, MA, USA

For further details, a list of speakers and to register, please visit: www.definiens.com/community/symposium.html


About Definiens
Definiens is the leading provider of image analysis and data mining solutions for life sciences, tissue diagnostics and clinical digital pathology. Definiens software provides detailed cell-by-cell readouts from target structures on whole tissue slides, and allows the correlation of this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and support better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives.

Definiens is headquartered in Munich, Germany and has offices throughout the United States.


Media Contact
Definiens AG
Dr Florian Leiss
Manager Marketing Communications
+49 (89) 2311-8024
This e-mail address is being protected from spambots. You need JavaScript enabled to view it